Grants and Contributions:
Title:
Midwestern US, UAE, Saudi Arabia, Iran, and Japan Export Market Development Project
Agreement Number:
943898
Agreement Value:
$58,500.00
Agreement Date:
Jan 8, 2020 - Oct 31, 2020
Description:
AX Pharmaceutical will attend leading industry tradeshows and conduct business development travel to promote our active pharmaceutical ingredients to new customers located in the Midwestern US, UAE, Saudi Arabia, Iran, and Japan.
Organization:
National Research Council Canada
Expected Results:
CanExport SMEs is designed to provide direct financial assistance to small- and medium-sized enterprises seeking to develop new export market opportunities and markets, especially in high-growth emerging markets.
Location:
Concord, Ontario, CA L4K 0J9
Reference Number:
172-2019-2020-Q4-943898
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
827880337
Recipient Type:
For-profit organization
Recipient's Legal Name:
AX Pharmaceutical Corp.
Federal Riding Name:
Thornhill
Federal Riding Number:
35104
Program:
CanExport SMEs
Program Purpose:
CanExport SMEs is designed to provide direct financial assistance to small- and medium-sized enterprises seeking to develop new export market opportunities and markets, especially in high-growth emerging markets.
Coverage:
CanExport SMEs projects lead to increased export diversification and growth for Canadian small and medium enterprises.
NAICS Code:
325410